At J.P. Morgan’s 41st annual healthcare conference, there was no shortage of innovative discussions. We’ve rounded up some of the biggest themes from this year’s conference:
Connected drug delivery devices are gaining traction among top pharma companies
As medication non-adherence continues to plague the global life sciences industry – more than $600 billion in annual revenue is lost1 – many pharmaceutical companies are evaluating new approaches to improving patient engagement, including embedded sensors that capture data through drug delivery devices. One of the biggest selling points for organizations is that connected drug delivery devices can play a huge role in boosting adherence and compliance. Devices that can detect and capture data around patient-administered therapy, such as dose timing, volume, and technique, have become an increasingly popular choice among leading organizations. Patients are more likely to refill and take their medications on time, and correctly, if they can be prompted to do so and have a record of dosing history.
With perpetually rising healthcare costs, soaring operating expenses, and plummeting profit margins, health systems are pressured to re-evaluate their care delivery models and shift their focus to value.
Implementing the right tools to enhance decision making and build care management capabilities for population health, risk stratification, and site-of-care optimization will be vital for navigating this actively evolving landscape. Digital health solutions are critical enablers of success, especially having demonstrated clinical and real-world outcomes in all reimbursement settings.
In an outcomes-based payment model, health systems can leverage digital solutions to:
A staggering 97% of medical practices experienced a negative financial impact at the beginning of the pandemic, including a 60% decrease in patient volume and a 55% decline in revenue.1 Nearly three years later, more than half of hospitals are still experiencing negative margins.2
To ensure success in this actively evolving landscape, health systems must equip themselves with the right tools to enhance decision making and reduce administrative burden through frictionless clinician experiences. Digital health solutions are critical enablers of success, especially having demonstrated clinical and real-world outcomes in all reimbursement settings.
In a traditional payment model, digital solutions can help health systems:
Health systems faced major headwinds in 2022: ongoing clinician burnout, soaring staffing shortages, and plummeting financial margins. Fortunately, the healthcare industry has been actively restructuring its landscape and building new momentum in reimbursement, value-based care, and patient engagement. With all the fundamental shifts to come in 2023, health systems have the most to gain… and the most to lose if they don’t take prompt action.
Here are the most pressing changes health systems can expect – and should immediately prepare for:
New CMS rulemaking on remote therapeutic monitoring is more practical for health systems
More than 90,000 new digital health solutions entered the market in 2020,1 and annual growth is expected to increase 27% over the next 8 years.2 For health systems, this creates an unprecedented opportunity to leverage digital solutions, especially considering: expanded reimbursement opportunities for remote monitoring, soaring patient engagement, and increased physician demand.
With so many digital options available, comprehensive partner evaluations are critical for identifying solutions with staying power, ensuring successful implementation, and developing the necessary infrastructure to support integration at scale. If health systems aren’t asking the right questions during their value assessments, they won’t see a return on their investments.
These are the top 5 questions health systems must consider before heading into their digital partner evaluations:
Health systems are under pressure to capitalize on healthcare’s growing digital landscape, especially with staffing shortages and clinician burnout at an all-time high. Without a concrete approach to integrating digital solutions into their care management strategies, health systems are at risk of losing time, physicians, patients, and money.
Propeller Health and its research partners presented five abstracts at this year’s European Respiratory Society (ERS) International Congress. Our latest research explored the relationship between respiratory comorbidities and healthcare utilization, the effect of digital health solutions on medication adherence and asthma control, and projected prevalence of COPD by the year 2050.
Read brief summaries of each abstract below or click the links to view them online.
Characterizing healthcare resource use among adults with COPD by presence of comorbidities
Between the rising global prevalence of chronic disease and a rapidly growing digital-first movement in healthcare, the development of connected drug delivery devices has increased significantly over the last several years.
Even before the COVID-19 pandemic, the connected drug delivery devices market was experiencing steady growth. By the end of 2020, the market had grown 23.8% compared to the previous year.1 This expansion indicates that more than ever, embedding electronics and sensors into drug delivery devices including inhalers and injector pens is becoming more widely adopted.
Healthcare is at an inflection point. In the United States, value-based models continue to grow, with value-based contracts expected to account for 22% of insured lives by 2025 – up 7% from current figures.1 At the same time, rising healthcare costs and changing government incentives are contributing to shifts in provider and payer demand.
So, what does all of this mean for pharmaceutical and life sciences companies?
Most people’s breathing is impacted by at least a few different things, which are called triggers. There may be times when you notice that you’re not breathing as well as you’d like to be. You may cough or feel out of breath. These reactions to triggers are called symptoms, and they aren’t random.
Here we’ll focus on triggers, why they matter and how we can help you figure out your triggers so you can better prepare for the day ahead.
A disruption to your schedule can easily throw off your adherence to your medication. You stop being able to take your dose in the morning, and suddenly you’re not taking it at all — and your symptoms are getting worse.
Here are three tips to take your dose even when your schedule changes.
1. Be intentional about changing your medication schedule.
If you have pollen allergies and asthma, the spring months can be quite a burden. Allergies can trigger asthma symptoms, causing wheezing, cough, chest tightness and shortness of breath. Here are five tips to manage your allergies during the spring months and avoid preventable asthma exacerbations.
If you have asthma or COPD, you may have noticed that cold weather affects your ability to breathe.
This may happen because cold air dries and irritates the airways, increasing inflammation and making it harder for you to breathe. You may find that you cough, wheeze or feel breathless more often when it’s cold outside.
It’s not always possible to stay inside all winter, so we’ve put together a few tips on how to manage your asthma and COPD during the colder months.
2020 has been a tough year. Which is all the more reason to look forward to our annual celebration of family and food. Thanksgiving is a chance to come together and take stock of our good fortunes.
But travelling, stress and even some foods can trigger asthma and COPD symptoms (plus COVID-19 is still a big concern). Read on to prepare…
Advice for a safe and happy Thanksgiving
Ahhhh, October! The month of ghouls, goblins and pumpkin spice everything. From big cities to tiny towns, Halloween is a favorite holiday of kids of all ages. But, like everything else, trick-or-treating is going to look different this year. Here’s some advice on keeping Halloween spooky and safe.
Yoga is an ancient practice that has become very popular in the U.S. over the past few years. Yoga combines poses (called asanas) along with breathing exercises and meditation. People practice yoga to stay fit, flexible and grounded. But can a yoga practice help people with asthma?
The Quick Take
There is some evidence showing that yoga may help people with asthma have a better quality of life. But there just hasn’t been enough research to say if yoga can help relieve or manage asthma symptoms.
Typically, this time of the year is all about back to school sales, labor day barbecues and the start of football season. But, things are different this year. We are making some progress controlling the spread of COVID-19. But as people start spending more time indoors, there’s concern about a second wave of infections. What does this mean for people with asthma?
The Quick Take
The best chance we have to get a handle on COVID-19 is by following the advice of local health officials. They’re most informed about the needs of particular communities, and different places are in different phases of reopening.”
Growing the Leading Asthma and COPD Management Solution
Jennifer Johns, VP of Strategic Accounts for Propeller, joins Redox’s
Sarah Bottjen for a conversation about growing the Propeller solution
with patients and providers and the challenges and best practices of marketing a digital health solution.
How Digital Inhalers Can Reveal the Impact of Air Quality on Clinical Outcome
Dr. Joan Casey from Columbia University and Dr. Meredith Barrett of Propeller Health and ResMed will discuss their peer-reviewed findings on how the closure or regulation of coal-fired power plants in the Louisville, KY area led to a significant reduction in air pollutants, as well as improvements in health outcomes for nearby residents with asthma.